In conclusion, our data indicated that HBV variants in the C region, particularly in M2RR, may contribute to HCC progress in chronic patients infected with the genotype C via immune evasion against the CD4 T cell-mediated immune response. Here, CD4 is linked to hepatocellular carcinoma.